Salvadori Daniel Gesua Sive's Form 4 filing
Abbott Laboratories (ABT) · filed Mar 4, 2024
- Accession no.
- 0001415889-24-006417
- Filed
- Mar 4, 2024
- Trade date
- Feb 29-Mar 1, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $114.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Salvadori Daniel Gesua SiveCIK 0001620564 | Officer (EXECUTIVE VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 29, 2024 | Common shares without par value | FTax withholdingDisposed | −8,874 | $120.05 | −$1,065,323.7 | 126,660 | Direct | |
| Mar 1, 2024 | Common shares without par value | SSaleDisposed | −963 | $118.50 | −$114,115.5 | 125,697 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.